サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363510

バイオロジカルインプラントの市場規模、シェア、動向分析レポート：製品別、投与形態別、用途別、地域別、セグメント予測、2023年～2030年

Biological Implants Market Size, Share & Trends Analysis Report By Product (Autografts, Allografts), By Mode of Administration (Surgical, Injectable), By Application (Cardiovascular Implants), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 147 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオロジカルインプラントの市場規模、シェア、動向分析レポート：製品別、投与形態別、用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月22日
発行: Grand View Research
ページ情報: 英文 147 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオロジカルインプラント市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のバイオロジカルインプラント市場規模は2030年までに136億1,000万米ドルに達し、2023年から2030年までのCAGRは7.2％を記録すると予測されています。

バイオロジカルインプラント市場は、心臓血管、整形外科、その他の軟部組織修復など様々な臨床用途の再建手術に移植片や臓器代替物の採用が増加していることが原動力となっています。これらの製品の使用に関連する主な課題は、再生と修復を促進するために、周囲の環境の生物学に特異的に適応できるような材料を組み込むことです。この課題を克服するために、生物学的なソースからこのようなデバイスを開発するための研究努力が行われており、その結果、今後の産業成長に影響を与えることになります。

複合材移植のプロセスの改良は、移植の全体的なプロセスに発展をもたらすことで、切断された指先の再移植に取り組む上で重要な役割を果たすと予想されます。さらに、この市場で活動する主要参入企業間の競合の高まりは、成長を加速させるインパクトの大きいレンダリング要因の1つです。

バイオロジカルインプラント市場レポートハイライト

  • 移植片の供給源やドナーによって、提供される製品は自家移植片、同種移植片、異種移植片に分類されます。2022年の売上シェアは異種移植片が50%超を占めています。しかし、同種移植片は同種に由来し、異物免疫移植反応の可能性がかなり低いため、採用率に影響を与え、急成長が期待されます。
  • 生物学的製剤は、心臓血管、整形外科、その他の軟組織インプラントなど、様々な用途に使用されています。軟組織製品は、歯科分野での製品の高い使用の結果として、2022年に最大のシェアを占めました。心血管インプラントは、現在のシナリオでは最も低い普及率を占めているが、生物学的ソースから得られる心血管ステントとバルブの需要は拡大すると予想され、その結果、このセグメントからの収益生成を後押ししています。
  • 外科的投与と注射による投与の中では、外科的投与が大きなシェアを占めると推定されます。移植片を外科的に組み込むための低侵襲技術のイントロダクションも、このセグメントの成長を促進する重要な要因の1つです。
  • 北米は、市場参入企業が広く存在し、この地域の人々の間で美容とヘルスケアに対する意識レベルが高いことから、50.3％の売上シェアで市場を独占しています。
  • アジア太平洋地域は、対象人口の存在と医療インフラの急速な改善により、組織工学製品およびバイオロジカルインプラントの需要を牽引し、今後数年間で最も速い成長を示すと推定されます。
  • この業界で事業を展開している主な企業には、Medtronic、NuVasive, Inc、Stryker Corporation、Conmed Corporation、CryoLife、Edwards LifeSciences Corporation、Acelity、Integra LifeSciences Corporation、Allergan Plc、RTI Surgical、IOP Ophthalmics、Organogenesis Inc、BioPolymer GmbH &Co.KG、Osiris Therapeutics、Baxter International、Vericel、Aplhatec Spine Inc、Maxigen Biotech Inc、Auto Tissue Berlin GmbH、MiMedx Group, Inc.
  • これらのプレーヤーは、それぞれの浸透を促進し、市場での存在感を高めるために、さまざまな事業戦略に取り組んでいます。これらの戦略には、より大きな収益シェアをつかむために、新規製品開発や共同活動に関与することによる地理的拡大が含まれます。例えば、2016年4月、Stryker Corporationは、Stanmore Implants Worldwide Limitedを買収しました。これは、同社が整形外科腫瘍外科医に差別化された技術を提供することを可能にし、予測期間の成長を促進すると期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオロジカルインプラント市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • バイオロジカルインプラント市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 バイオロジカルインプラント：製品別推定・動向分析

  • バイオロジカルインプラント市場：重要なポイント
  • 生体インプラント市場：動向と市場シェア分析、2022年および2030年
  • 自家移植片
  • 同種移植片
  • 異種移植片

第5章 バイオロジカルインプラント：用途別推定・動向分析

  • バイオロジカルインプラント市場：重要なポイント
  • 生体インプラント市場：動向と市場シェア分析、2022年および2030年
  • 心臓血管インプラント
  • 整形外科用インプラント
  • その他の軟部組織インプラント

第6章 バイオロジカルインプラント：投与形態別推定・動向分析

  • バイオロジカルインプラント市場：重要なポイント
  • 生体インプラント市場：動向と市場シェア分析、2022年および2030年
  • 手術
  • 注射

第7章 バイオロジカルインプラント市場：地域別推定・動向分析

  • 地域別の展望
  • 地域別のバイオロジカルインプラント市場：重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Integra LifeSciences
    • NuVasive, Inc.
    • Edwards Lifesciences Corporation
    • Stryker
    • LifeCell International Pvt. Ltd.
    • Medtronic
    • Osteotec Limited
    • RTI Surgical
    • BioPolymer GmbH & Co KG
    • Johnson & Johnson Private Limited
    • Baxter
    • Vericel
    • ATEC Spine, Inc
    • Artivion, Inc
    • Maxigen Biotech Inc.
    • Implandata Ophthalmic Products GmbH
    • CONMED Corporation
    • AbbVie Inc.
    • BioTissue
    • Auto Tissue Berlin GmbH
    • MIMEDX Group, Inc.
    • Organogenesis Inc.
    • Smith+Nephew
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 5 North America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 9 Canada biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 12 Europe biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 15 Europe biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 19 UK biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 22 France biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 23 France biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 24 France biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 25 Italy biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 28 Spain biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 31 Sweden biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 34 Norway biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 37 Denmark biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 47 China biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 48 China biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 49 China biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 50 India biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 51 India biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 52 India biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 53 Australia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 56 Thailand biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 59 South Korea biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 62 Latin America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 65 Latin America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 69 Mexico biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 72 Argentina biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 85 UAE biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 88 Kuwait biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait biological implants market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Biological implants: Market outlook
  • Fig. 8 Biological implants: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Biological implants market driver impact
  • Fig. 14 Biological implants market restraint impact
  • Fig. 15 Biological implants market strategic initiatives analysis
  • Fig. 16 Biological implants market: Product movement analysis
  • Fig. 17 Biological implants market: Product outlook and key takeaways
  • Fig. 18 Autografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Allografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Xenografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biological implants market: Application movement analysis
  • Fig. 22 Biological implants market: Application outlook and key takeaways
  • Fig. 23 Cardiovascular implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Orthopedic implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other soft tissue implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Biological implants market: Mode of administration movement analysis
  • Fig. 27 Biological implants market: Mode of administration outlook and key takeaways
  • Fig. 28 Surgical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global biological implants market: Regional movement analysis
  • Fig. 31 Global biological implants market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-270-9

Biological Implants Market Growth & Trends:

The global biological implants market size is expected to reach USD 13.61 billion by 2030, according to a new report by Grand View Research, Inc.., registering a CAGR of 7.2% from 2023 to 2030. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

Biological Implants Market Report Highlights:

  • Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2022 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune implants reaction, thereby influencing adoption rate.
  • Biological serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2022 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
  • Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
  • North America dominated the market with a revenue share of 50.3% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
  • Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
  • Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
  • These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Mode of Administration
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Mode of administration outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Biological Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Biological Implants Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Biological Implants: Product Estimates & Trend Analysis

  • 4.1. Biological Implants Market: Key Takeaways
  • 4.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Autografts
    • 4.3.1. Autografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Allografts
    • 4.4.1. Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Xenografts
    • 4.5.1. Xenografts market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biological Implants: Application Estimates & Trend Analysis

  • 5.1. Biological Implants Market: Key Takeaways
  • 5.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Cardiovascular Implants
    • 5.3.1. Cardiovascular implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Orthopedic Implants
    • 5.4.1. Orthopedic implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Other Soft Tissue Implants
    • 5.5.1. Other soft tissue implants market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biological Implants: Mode of Administration Estimates & Trend Analysis

  • 6.1. Biological Implants Market: Key Takeaways
  • 6.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Surgical
    • 6.3.1. Surgical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Injectable
    • 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biological Implants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Biological Implants Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Integra LifeSciences
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. NuVasive, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Edwards Lifesciences Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Stryker
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. LifeCell International Pvt. Ltd.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Osteotec Limited
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. RTI Surgical
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. BioPolymer GmbH & Co KG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Johnson & Johnson Private Limited
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Baxter
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Vericel
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. ATEC Spine, Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Artivion, Inc
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Maxigen Biotech Inc.
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. Implandata Ophthalmic Products GmbH
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. CONMED Corporation
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. AbbVie Inc.
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives
    • 8.2.19. BioTissue
      • 8.2.19.1. Company overview
      • 8.2.19.2. Financial performance
      • 8.2.19.3. Product benchmarking
      • 8.2.19.4. Strategic initiatives
    • 8.2.20. Auto Tissue Berlin GmbH
      • 8.2.20.1. Company overview
      • 8.2.20.2. Financial performance
      • 8.2.20.3. Product benchmarking
      • 8.2.20.4. Strategic initiatives
    • 8.2.21. MIMEDX Group, Inc.
      • 8.2.21.1. Company overview
      • 8.2.21.2. Financial performance
      • 8.2.21.3. Product benchmarking
      • 8.2.21.4. Strategic initiatives
    • 8.2.22. Organogenesis Inc.
      • 8.2.22.1. Company overview
      • 8.2.22.2. Financial performance
      • 8.2.22.3. Product benchmarking
      • 8.2.22.4. Strategic initiatives
    • 8.2.23. Smith+Nephew
      • 8.2.23.1. Company overview
      • 8.2.23.2. Financial performance
      • 8.2.23.3. Product benchmarking
      • 8.2.23.4. Strategic initiatives